1. Predictive validity of interleukin 6 (IL-6) for the mortality in critically ill COVID-19 patients with the B.1.617.2 (Delta) variant in Vietnam: a single-centre, cross-sectional study.
- Author
-
Nguyen CV, Luong CQ, Dao CX, Nguyen MH, Pham DT, Khuat NH, Pham QT, Hoang DT, Nguyen AD, Nguyen PM, Cao DD, Pham DT, Nguyen TQ, Nong VM, Dang DT, Nguyen DT, Nguyen VD, Le TQ, Nguyen VK, Ngo HD, Nguyen DV, Pham TT, Nguyen DT, Nguyen NT, Do TD, Huynh NT, Phan NT, Nguyen CD, Vo KH, Vu TT, Do CD, Dang TQ, Vu GV, Nguyen TC, and Do SN
- Subjects
- Humans, Male, Middle Aged, Female, Cross-Sectional Studies, Vietnam, Aged, Intensive Care Units statistics & numerical data, Biomarkers blood, Predictive Value of Tests, ROC Curve, COVID-19 mortality, COVID-19 blood, Interleukin-6 blood, Critical Illness mortality, SARS-CoV-2, Hospital Mortality
- Abstract
Objectives: To investigate the serum IL-6 levels and their rate of change in predicting the mortality of critically ill patients with COVID-19 in Vietnam., Design: A single-centre, cross-sectional study., Setting: An Intensive Care Centre for the Treatment of Critically Ill Patients with COVID-19 in Ho Chi Minh City, Vietnam., Participants: We included patients aged 18 years or older who were critically ill with COVID-19 and presented to the study centre from 30 July 2021 to 15 October 2021. We excluded patients who did not have serum IL-6 measurements between admission and the end of the first day., Primary Outcome Measures: The primary outcome was hospital all-cause mortality., Results: Of 90 patients, 41.1% were men, the median age was 60.5 years (Q1-Q3: 52.0-71.0), and 76.7% of patients died in the hospital. Elevated IL-6 levels were observed on admission (41.79 pg/mL; Q1-Q3: 20.68-106.27) and on the third day after admission (72.00 pg/mL; Q1-Q3: 26.98-186.50), along with a significant rate of change in IL-6 during that period (839.5%; SD: 2753.2). While admission IL-6 level (areas under the receiver operator characteristic curve (AUROC): 0.610 (95% CI: 0.459 to 0.761); cut-off value ≥15.8 pg/mL) and rate of change in IL-6 on the third day of admission (AUROC: 0.586 (95% CI: 0.420 to 0.751); cut-off value ≥-58.7%) demonstrated poor discriminatory ability in predicting hospital mortality, the third day IL-6 rate of change from admission ≥-58.7% (adjusted OR: 12.812; 95% CI: 2.104 to 78.005) emerged as an independent predictor of hospital mortality., Conclusions: This study focused on a highly selected cohort of critically ill COVID-19 patients with a high IL-6 level and mortality rate. Despite the poor discriminatory value of admission IL-6 levels, the rate of change in IL-6 proved valuable in predicting mortality. To identify critically ill COVID-19 patients with the highest risk for mortality, monitoring the serial serum IL-6 measurements and observing the rate of change in serum IL-6 levels over time are needed., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF